Clinical trial
A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.
NCT00274560
Study timeline
Study start (actual)2002-05-01Date precision: day
Registry last updated2023-12-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Disease, Chronic Obstructiveunresolved
Interventions
TiotropiumDRUG · verified · RxNorm: tiotropium
SalmeterolDRUG · verified · RxNorm: salmeterol
Sponsors & collaborators
Boehringer Ingelheimlead sponsor
Mapped research locations
AthensGreece3IstanbulTurkey (Türkiye)2StockholmSweden2LisbonPortugal2HoustonTexas, United States1PhiladelphiaPennsylvania, United States1BirminghamAlabama, United States1PortlandOregon, United States1PhoenixArizona, United States1DenverColorado, United States1Oklahoma CityOklahoma, United States1CharlestonSouth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00274560 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.